Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/08/19 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
48 | |
| 11/07/19 | Current report filing |
|
9 | ||
| 10/07/19 | Current report filing |
|
20 | ||
| 08/29/19 | Prospectus filed pursuant to Rule 424(b)(5) |
|
60 | ||
| 08/29/19 | Current report filing |
|
5 | ||
| 08/19/19 | Current report filing |
|
3 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 |